EUVIMEDEUVIMED entdecken
Crossref

ALDH2 rs671 variant enhances platelet activation and thrombosis by disrupting mitochondrial complex I assembly

Haoxuan Zhong, Maieryemu Waresi, Zhiyong Qi, Luning Zhou, Wei Zhang, Xiaolei Sun, Liping Han, Zhihan Chen, Wenxuan Zhou, Peng Zhang, Huajie Xu, Si Zhang iD und 3 weitere

Cardiovascular Research · 2025

DOI: 10.1093/cvr/cvaf194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiovascular Research, 2025. Verfasst von Haoxuan Zhong und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Shanghai 200032, Chi…. Hauptthemen laut MEDLINE: Aldehyde Dehydrogenase, Mitochondrial, Platelet Activation, Blood Platelets, Thrombosis. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: Noncommunicable Chronic Diseases-National Science and Technology, Clinical Research Special Fund, Fudan University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

Aldehyde dehydrogenase 2 (ALDH2) is a critical mitochondrial enzyme responsible for aldehyde detoxification and maintenance of redox homeostasis. The rs671 variant, a prevalent loss-of-function mutation in East Asian populations (30–50% carrier frequency), diminishes ALDH2 enzymatic activity by 60–90% and is associated with elevated thrombotic risk. Although platelet activation is known to play a central role in thrombosis formation, the specific contribution of ALDH2 to this process has not been fully elucidated. This study was designed to investigate the functional role of ALDH2 in platelet activation and thrombus formation. Methods and results Platelet activation and thrombus formation were assessed in wild-type (WT), systemic Aldh2-knockout (Aldh2−/−), and systemic Aldh2E487K/E487K-knockin mice, as well as patients with coronary artery disease (CAD) and healthy volunteers. Mechanistic studies were performed using immunoprecipitation, mass spectrometry, and RNA sequencing. Nicotinamide adenine dinucleotide (NAD+) supplementation was evaluated for its potential to mitigate the effects of ALDH2 variant. Patients with CAD carrying the ALDH2 rs671 variant exhibited enhanced platelet reactivity to collagen compared with those without the variant. Collagen-induced platelet aggregation, granule release, and integrin αIIbβ3 activation were significantly enhanced in Aldh2−/− mice compared with WT mice. Mechanistically, ALDH2 deficiency disrupted mitochondrial complex I assembly and function. This increased reactive oxygen species production via the collagen/glycoprotein VI (GPVI)/NAD phosphate oxidase 1 (NOX1) pathway and enhanced platelet reactivity. Similar results were observed in Aldh2E487K/E487K-knockin mice. NAD+ supplementation effectively counteracted ALDH2 variant-induced platelet hyperreactivity and thrombosis in both mice and human subjects.

Conclusion

The ALDH2 rs671 variant enhances collagen-induced platelet activation and thrombosis by impairing mitochondrial complex I assembly and function. NAD+ supplementation offers a promising strategy to mitigate thrombotic risk in individuals carrying this variant.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Aldehyde Dehydrogenase, MitochondrialPlatelet ActivationBlood PlateletsThrombosisElectron Transport Complex IMitochondriaAnimalsHumansMice, KnockoutDisease Models, AnimalMaleCase-Control StudiesReactive Oxygen SpeciesMice, Inbred C57BLFemaleGenetic Predisposition to DiseaseSignal TransductionNADNADPH Oxidase 1Middle AgedPhenotype

Stichwörter der Autor:innen

Aldehyde dehydrogenase 2Mitochondrial complex INAD+Platelet activationROSThrombosis

Substanzen

Aldehyde Dehydrogenase, MitochondrialALDH2 protein, mouseElectron Transport Complex IALDH2 protein, humanReactive Oxygen SpeciesNOX1 protein, mouseNADNADPH Oxidase 1

Autor:innen und Institutionen

  • Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, 180 Fenglin Road, Shanghai 200032, China.
  • Department of Cardiology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
  • Department of Biochemistry and Molecular Biology, NHC Key Laboratory of Glycoconjugates Research, School of Basic Medical Sciences, Fudan University, Shanghai, China.
  • National Clinical Research Center for Interventional Medicine, 180 Fenglin Road, Shanghai 200032, China.
  • State Key Laboratory of Cardiovascular Diseases, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China.
  • NHC Key Laboratory of Ischemic Heart Diseases, Zhongshan Hospital, Fudan University, 180 Fenglin Road, Shanghai 200032, China.

ORCID-Profile: Si Zhang, Junbo Ge

Förderung

  • Noncommunicable Chronic Diseases-National Science and Technology
  • Clinical Research Special Fund
  • Fudan University
  • National Natural Science Foundation of China

Zitieren

APA

Zhong, H., Waresi, M., Qi, Z., Zhou, L., Zhang, W., Sun, X., Han, L., Chen, Z., Zhou, W., Zhang, P., Xu, H., Zhang, S., Wu, H., Sun, A., & Ge, J. (2025). ALDH2 rs671 variant enhances platelet activation and thrombosis by disrupting mitochondrial complex I assembly. Cardiovascular Research. https://doi.org/10.1093/cvr/cvaf194

Vancouver

Zhong H, Waresi M, Qi Z, Zhou L, Zhang W, Sun X, et al. ALDH2 rs671 variant enhances platelet activation and thrombosis by disrupting mitochondrial complex I assembly. Cardiovascular Research. 2025. doi:10.1093/cvr/cvaf194

BibTeX
@article{Zhong2025,
  author = {Zhong, Haoxuan and Waresi, Maieryemu and Qi, Zhiyong and Zhou, Luning and Zhang, Wei and Sun, Xiaolei and Han, Liping and Chen, Zhihan and Zhou, Wenxuan and Zhang, Peng and Xu, Huajie and Zhang, Si and Wu, Hongyi and Sun, Aijun and Ge, Junbo},
  title = {ALDH2 rs671 variant enhances platelet activation and thrombosis by disrupting mitochondrial complex I assembly},
  journal = {Cardiovascular Research},
  year = {2025},
  doi = {10.1093/cvr/cvaf194}
}
Kostenlos starten →